Connect with us

Hi, what are you looking for?

Thursday, Oct 2, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Canadian medical cannabis exports to Germany skyrocket in 2024
Canadian medical cannabis exports to Germany skyrocket in 2024
Photo credit: Tilray Medical -- one of Australia's top suppliers in Canada

Cannabis

Canadian medical cannabis exports to Australia skyrocket in 2024

Canada is dominating the nation’s medicinal marijuana sector

Canada has been dominating the medical cannabis sector in a country known for kangaroos and scary bugs.

Canadian medical cannabis imports into Australia rose by 74 per cent year-over-year in 2024, according to data released by the Australian government on Sept. 30.

Canadian companies exported over 62,000 kilograms of cannabis to the land down under last year in comparison to just under 36,000 in 2023. This quantity in 2024 accounted for approximately 80 per cent of the total received by Australia, the nation’s Office of Drug Control specified.

Aurora Cannabis Inc (TSE: ACB) (NASDAQ: ACB) (FRA: 21P), Village Farms International Inc (NASDAQ: VFF) (FRA: 02V), Canopy Growth Corp (TSE: WEED) (NASDAQ: CGC) (FRA: 11L), Tilray Brands Inc (TSE: TLRY) (NASDAQ: TLRY) (FRA: 2HQ) and Organigram Global Inc (TSE: OGI) (NASDAQ: OGI) (FRA: 0OG) have been leading the charge with these shipments.

Aurora ships EU-GMP-certified flower and extracts, Village Farms exports indoor-grown BC bud and Canopy Growth sends medical concentrates. Furthermore, Tilray’s medical subsidiary exports high-THC cultivars and Organigram focuses on shipping sustainably grown strains.

Australian patients are permitted to access medical cannabis for conditions such as chronic pain, multiple sclerosis, epilepsy and chemotherapy-linked nausea. Approximately 1 million prescriptions were issued to citizens throughout last year. It has been legal nationwide since 2016.

The rapid rise in medical cannabis use has become cause for concern among key health organizations in the country. Only 19,000 prescriptions were handed out in 2019.

This week, the New South Wales branches of The Royal Australian College of General Practitioners, Australian Medical Association, Pharmacy Guild of Australia and Pharmaceutical Society of Australia wrote to the state’s health minister advocating for greater selectivity in the prescription process.

The University of Sydney also published an article this week voicing concerns about the side effects of medical cannabis and its mental health implications. It references a Canadian study about links between marijuana usage and schizophrenia from February.

“Prescribing data reveals eight practitioners wrote more than 10,000 medicinal cannabis scripts in a six-month period,” the university said, calling for enhanced oversight as well.

Read more: Canadian cannabis industry added C$16B to nation’s GDP last year

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

Follow Rowan Dunne on LinkedIn

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Bitcoin

The watchdog found 33 instances where the company failed to file suspicious transaction reports

Cannabis

The state's tax on legal cannabis will revert back to 15%

Mining

Champagne pointed to Canada’s critical mineral reserves, energy resources and shipbuilding expertise as key strengths

Cannabis

ISHI has 'sophisticated AI-driven cultivation systems,' according to the Israeli cannabis producer